GSK has rejected the offers, which it said were too low. It’s planning to spin off the division later this year, under pressure from shareholders including hedge fund Elliott Investment Management.

GSK rejects 50-billion-pound Unilever offer for consumer assets By Siddharth Cavale, Ludwig Burger and Mrinmay Dey January 15, 202210:18 AM PSTUpdated January 15, 2022 ...

Hindustan Unilever (HUL) faces a Rs 962.75 crore tax demand from the Income Tax Department over non-deduction of TDS on a Rs 3,045 crore payment for acquiring GSK’s India Health Food Drink IPR ...

GSK and Pfizer set up the joint venture in 2019, intending to exit the business so both can focus on higher-profit innovative drugs and vaccines. The unit, which includes popular brands such as ...

Unilever PLC UL -0.03% said it wants to push further into health, beauty and hygiene products at the expense of slower-growing food brands, laying out its biggest strategic shift in years after ...

Meanwhile, HUL shares were trading flat at Rs 2,819 in early deals on BSE today. Market cap of the FMCG firm stood at Rs 6.61 lakh crore.

All told, GSK generated 29.3 billion pounds sterling in revenues last year, a 13% increase over 2021 at constant exchange rates. The company's total profit totaled 6.4 billion pounds, a 31% ...

Unilever CEO to retire at end of 2023 after GSK setback Alan Jope became CEO of Unilever in 2019, after Kraft Heinz Co.’s failed bid to acquire the company for $143 billion.

Unilever CEO set to leave after GSK debacle, arrival of activist investor By Richa Naidu September 26, 202211:55 AM PDTUpdated September 26, 2022 Summary Companies Law Firms ...

With data expected in therapy areas including respiratory, diabetes, oncology, HIV and rare diseases, Witty said GSK could file drug applications for 10 new products during 2012.